Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study

NCT04658979 | Unknown

• 1 other identifier: 21983
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

Chronic pulmonary disease like interstitial lung disease (ILD) and chronic obstructive lung disease (COPD) are a significant health problem in Canada and around the world. In addition to the respiratory impairment resulting to a progressive dyspnea, these diseases are also characterized by a decrease in exercise tolerance and muscle dysfunction which affect the patient's quality of life. Respiratory rehabilitation is the cornerstone of the management of chronic disease and it includes a set of personalized care mainly delivered in person by a transdisciplinary team and with the objectives of reducing the symptoms felt by the participants and improving their physical and psychosocial condition. The current containment due to the COVID-19 pandemic increase the sedentary behavior of patients and prevents the holding of any respiratory rehabilitation activity. In this context, tele-rehabilitation appears to be a particularly well-suited solution because it would make it possible to offer a respiratory rehabilitation in a safe and effective manner while minimizing contact with the participants. Although some studies support the feasibility of this intervention, more data is needed to validate its routine clinical application. The main objective of this study is to verify the safety and the feasibility of delivering pulmonary rehabilitation treatments entirely at home via a telerehabilitation patform developed at the Institut universitraire de cardiologie et de pneumologie de Québec (IUCPQ), and document its effectiveness in people with chronic respiratory disease. The secondary objectives will be: 1) to explore the effects of a telerehabilitation programm on exercise tolerance, muscle function, functional capacity and quality of life, and 2) to assess the satisfaction of participants and health care providers with telerehabilitation.

Conditions

Chronic Pulmonary Disease

Keywords

Pulmonary Telerehabilitation; Safety; Feasibility; Interstitial lung disease; Chronic obstructive lung disease

Outcome Measures

Primary Outcomes (3)

• Feasability - Patients´ satisfaction with the program between baseline and the up to 12 weeks follow-up

  Patient's satisfaction will be evaluated by a questionnaire including 7 questions on his feeling of competence with regard to the program, based on an 8-point Likert scale (0 to 7).

  12 weeks

• Feasability - Health care professionals' receptivity

  Health care professionals' receptivity towards the tele-rehabilitation will be assess by 18 questions based on an 6-point scale (0 to 5).

  12 weeks

• Feasibility - Patients' satisfaction with the health care received

  Patient's satisfaction will be evaluated by a questionnaire including 23 questions based on a 4-point scale (1 to 4).

  12 weeks

Secondary Outcomes (9)

• Quality of life by questionnaire

  12 weeks

• Dyspnea level

  12 weeks

• Exercise capacity

  12 weeks

• Exercise capacity

  12 weeks

• Functionnal capacity

  12 weeks

Study Arms (1)

Intervention group

EXPERIMENTAL

Other: Pulmonary tele-rehabilitation

Interventions

Pulmonary tele-rehabilitation OTHER

All the participant will by include in a tele-rehabilitation program who will be based on an 12-week intervention including therapeutic education and self-management sessions and training sessions, delivered through a videoconferencing application. All interventions will be under the supervision of a rehabilitation professional from the Pavillon de prévention des maladies cardiovasculaire (PPMC) and modeled according to the recommendations of the ATS/ERS.

Intervention group

Eligibility Criteria

• Age: 20 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• The patient already participate to the telerehabilitation program in the PPMC at IUCPQ

Sponsors & Collaborators

• Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec: lead
• Fondation IUCPQ: collaborator

Study Sites (1)

Institut universitaire de cardiologie et de pneumologie de Québec

Québec, Quebec, G1V 4G5, Canada

RECRUITING

MeSH Terms

Conditions

Lung Diseases, Interstitial; Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Didier Saey, Ph.D

  Institut universitaire de cardiologie et de pneumologie de Québec -ULaval

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Didier Saey, Ph.D

CONTACT

418-656-8711; didier.saey@criucpq.ulaval.ca

Jany Harvey, M.Sc.

CONTACT

418-656-8711; jany.harvey@criucpq.ulaval.ca

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal investigator

Study Record Dates

• First Submitted: December 2, 2020
• First Posted: December 9, 2020
• Study Start: December 1, 2020
• Primary Completion: March 1, 2021
• Study Completion: January 1, 2022
• Last Updated: December 10, 2020

Record last verified: 2020-12

Locations

CA (1)